LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice

por Park, Jong-Gil, Jeongs, Se-Jin, Yu, Jinha, Kim, Gyudong, Jeong, Lak Shin, Oh, Goo Taeg
Publicado 2018